Brad is a molecular and cellular biologist by training. He has worked with the MiKTMC group since early 2014 after completion of post-doctoral work at The University of Michigan. His expertise within the MiKTMC team includes Next Generation Sequencing and Lab Management.

As an experimental biologist, Brad hopes to contribute his knowledge to the field of Chronic Kidney Disease and make a positive impact on patients lives.